Assessment of the Molecular Diagnostic Market for 38 NA Tests in UK, 2011 - FOX5 Vegas - KVVU

Assessment of the Molecular Diagnostic Market for 38 NA Tests in UK, 2011

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE Reportlinker

NEW YORK, Feb. 21, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Assessment of the Molecular Diagnostic Market for 38 NA Tests in UK, 2011

http://www.reportlinker.com/p0884271/Assessment-of-the-Molecular-Diagnostic-Market-for-38-NA-Tests-in-UK-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Update of the 2009 started comprehensive European market assessment for molecular diagnostics from the end user perspective. Hospital and private laboratories have been surveyed to collect information on NA tests, test volumes, used platforms and technologies (amplification & detection) and reagents. For data reliability and accurate projections at segment level a 3 step methodology has been applied:
Step 1: Identification of the total number of laboratories
Step 2: Identification of the total number of laboratories using NA technologies (several units per hospital)
Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 38 NA tests has been provided to the labs for structured data entry. The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), TMA, LCR, NASBA, SDA, HCA, bDNA.

dii is an international market research company entirely specialised in healthcare markets providing market information and support to strategic business decisions. In cooperation with key industry we have desigend the Continuous European Molecular Market Assessment which has been realized in 2009 and 2011 with the 2 main objectives:
1) Assess the market for molecular diagnostics (# of labs using which technology, test volumes, platforms and reagents)
2) Understand long term trends and needs

Total number of clinical diagnostic labs by segment: small, medium and large hospitals, independent (private) labs
Number of clinical diagnostic NA labs by segment: small, medium and large hospitals, independent (private) labs
# of lab performing test by test types (Virus: Adenovirus, CMV, Enterovirus, EBV VL, HBV resistance, HBV Viral Load , HCV Genotyping , HCV qual, HCV Viral Load , HIV Genotyping , HIV qual, HIV Viral Load , HPV, HPV Genotyping, HSV 1 & 2, Influenza A, B, Norovirus, RSV, VZV, Bacteria: C. Diff, CT, CT/NG, GAS, GBS, MRSA, MTB, NG, VRE, Coagulation: Factor II, Factor V Leiden, Genetics: CF, Fragile X, Her2Neu, HLA Typing, Oncology: BRAF, EGFR, K RAS, BCR / ABL)
Total # of test/results per test type & growth rate
Market shares: for amplification & detection platforms and reagents be test type (Roche Diagnostics, Innogenetics, Abbott, Bio-Rad, bioMérieux, Stratagene, Applied Biosystems, Qiagen, Siemens, Cepheid, Digene)
Trends

Companies mentioned

Roche Diagnostics, Innogenetics, Abbott, Bio-Rad, bioMérieux, Stratagene, Applied Biosystems, Qiagen, Siemens, Cepheid, Digene,

To order this report:
Assessment of the Molecular Diagnostic Market for 38 NA Tests in UK, 2011

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

©2012 PR Newswire. All Rights Reserved.